Darbin O, Wichmann T. Effects of striatal GABA A -receptor blockade on striatal and cortical activity in monkeys. J Neurophysiol 99: 1294-1305, 2008. First published January 23, 2008 doi:10.1152/jn.01191.2007. To elucidate the role of ambient striatal ␥-aminobutyric acid (GABA) in the regulation of neuronal activity in the basal ganglia-thalamocortical circuits, we studied the effects of blocking striatal GABA A receptors on the electrical activities of single striatal neurons, on local field potentials (LFPs) in the striatum, and on motor cortical electroencephalograms (EEGs) in two monkeys. Striatal LFPs were recorded with a device that allowed us to simultaneously record field potentials and apply drugs by reverse microdialysis at the same site. Administration of the GABA A -receptor antagonist gabazine (SR95531, 10 and 500 M) induced large-amplitude LFP fluctuations at the infusion site, occurring every 2-5 s for about 2 h after the start of the 20-min drug administration. These events were prevented by cotreatment with a GABA A -receptor agonist (muscimol, 100 M) or a combination of ionotropic glutamate receptor antagonists , each given at 100 M). Gabazine (10 M) also increased the firing of single neurons recorded close to the injection site, but in most cases there was no correlation between single-neuron activity and the concomitantly recorded LFP signals from the same striatal region. In contrast, intrastriatal application of gabazine increased the correlation between striatal LFPs and EEG, and resulted in the appearance of recurrent EEG events that were temporally related to the striatal LFP events. These data provide evidence that a GABAergic "tone" in the monkey striatum controls the spontaneous activity of striatal neurons, as well as the level of striatal and cortical synchrony.
I N T R O D U C T I O N
The striatum is anatomically the most prominent nucleus of the basal ganglia and many of the proposed functions of the basal ganglia have been linked to synaptic processing among cells in the striatum. These functions include possible roles in "focusing" of cortical activity (e.g., Mallet et al. 2005; Ouyang et al. 2007) or in procedural and habit learning (see, e.g., Frank and Claus 2006; Graybiel 2005; Hikosaka et al. 2002; Laubach 2005; Morris et al. 2004; Schultz et al. 2003) . The principal striatal neuron types that are involved in these interaction are the medium-sized spiny neurons (MSNs) and the GABAergic and cholinergic interneurons. MSNs receive glutamatergic inputs from the cerebral cortex and from different nuclei of the thalamus (e.g., Djurfeldt et al. 2001; Mallet et al. 2006; Parent and Parent 2006; Slaght et al. 2004; Smith et al. 2004 ) and send projections to the external and internal pallidal segments, and to the substantia nigra pars reticulata (GPe, GPi, and SNr, respectively), as part of larger basal ganglia-thalamocortical loops (see review by DeLong and Wichmann 2007).
There are several types of GABAergic interneurons. Among them, the parvalbumin-positive "fast-spiking" cells have recently received attention because of their potential role in center-surround-type inhibitory processing (e.g., Mallet et al. 2005) . These cells are targeted by glutamatergic inputs from the cerebral cortex (e.g., Mallet et al. 2005 ) and innervate neighboring MSNs (Kawaguchi et al. 1995; Tepper and Bolam 2004; . Another important striatal interneuron type is the large cholinergic, "tonically active" aspiny interneuron. These cells receive glutamatergic projections from the intralaminar nuclei of the thalamus (Aosaki et al. 1994; Cragg 2006; Lapper and Bolam 1992; Matsumoto et al. 2001; Meredith and Wouterlood 1990; Sidib é and Smith 1999) and GABAergic inputs from MSN axon collaterals (Anderson et al. 1993; Bennett and Wilson 1998; DeBoer and Westerink 1994; Zackheim and Abercrombie 2005) . Cholinergic interneurons mainly target MSNs, with few terminations on GABAergic parvalbumin-containing interneurons (Tepper and Bolam 2004) . At the cellular level, acetylcholine may reduce striatal glutamatergic transmission at corticostriatal synapses (Calabresi et al. 1998 (Calabresi et al. , 2000 Hernandez-Echeagaray et al. 1998; Malenka and Kocsis 1988; Pakhotin and Bracci 2007; Sugita et al. 1991) and attenuate GABAergic inhibition of MSNs (Koos and Tepper 2002; Perez-Rosello et al. 2005) .
All classes of striatal neurons receive prominent inhibitory GABAergic inputs. Although these inhibitory interactions are likely to be essential for striatal processing, details of the actions of ␥-aminobutyric acid (GABA) in the striatum and the relevance of a background level of GABA are only beginning to emerge. GABA receptors are found at pre-or postsynaptic locations in almost all neuronal elements in the striatum, but GABA A receptors are mostly postsynaptic heteroreceptors (Fujiyama et al. 2000; Waldvogel et al. 2004) . Presynaptic GABA B receptors are known to regulate glutamatergic inputs to the striatum (Charara et al. 2000; Kaneda and Kita 2005; Lacey et al. 2005; Nisenbaum et al. 1992) .
Studies in rats have shown that MSNs are under tonic GABAergic inhibition (e.g., Kita 1996; Nisenbaum et al. 1992) . Based on electrophysiologic studies in vivo in rats, it has been proposed that GABAergic interactions between the fast-spiking interneurons and MSNs may constitute a "centersurround" inhibitory system by which the activity of transtriatal circuits may be focused (Mallet et al. 2005) and that dysfunction of this system may contribute to the development of movement abnormalities in Parkinson's disease (Mallet et al. 2006) . Other proposals, such as the notion that GABAergic transmission may regulate the level of synchrony between neuronal elements in the striatum, are currently debated, with both evidence in favor of (Czubayko and Plenz 2002; Koos et al. 2004; Nicola et al. 2004; Taverna et al. 2004; Tecuapetla et al. 2005; Tunstall et al. 2002; Venance et al. 2004 ) and evidence against (Jaeger et al. 1994 (Jaeger et al. , 1995 Stern et al. 1998) this possibility.
In the experiments reported here, we investigated the effects of GABA A -receptor blockade in the striatum of awake nonhuman primates, to examine the functional relevance of ambient GABA in the monkey striatum. We found that GABA Areceptor blockade not only increased neuronal spiking in the striatum, as was expected in light of the earlier studies in rodents, but that it also induced the development of striking changes in striatal local field potentials (LFPs) and in the simultaneously recorded motor cortical electroencephalographic (EEG) activity. The results demonstrate that ambient GABA in the monkey striatum strongly inhibits firing activity of striatal neurons and limits synchronous striatal and cortical activity.
M E T H O D S

Animals and surgical procedures
All experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (ILAC/OLAW 1996) and the PHS Policy on Humane Care and Use of Laboratory Animals (amended 2002). All procedures were approved by the Animal Care and Use Committee at Emory University.
Two female rhesus monkeys (4 -6 kg) were studied. The animals were first trained to accept handling by the investigators and to be seated in a primate chair. Both animals were used for the microdialysis and LFP recording sessions. In addition, one of them was used for single-neuron recording studies. After the acclimatization procedures, the animals underwent surgery to prepare them for the subsequent series of recording sessions. Under aseptic conditions and gas anesthesia (1-2.5% isoflurane), stainless steel recording chambers were affixed to the animal's skull, stereotactically aimed at the putamen at a 50°angle from the vertical in the coronal plane. Two silver-ball EEG electrodes were positioned to target the primary motor cortex (M1). The chamber, EEG electrodes, and head-stabilizing bolts were attached to the skull with dental acrylic. The recording sessions began 1 month after surgery.
LFP recording device
LFPs were recorded with ultrafine wires that were incorporated into microdialysis probes (Darbin et al. 2006) . The microdialysis probes were acutely introduced into the monkey striatum and were used to deliver drugs via reverse microdialysis. The probes consisted of a 3-mm-long section of microdialysis membrane (Hollow Fiber Bundles; molecular weight cutoff: 13 kDa; Spectra/Por RC; Spectrum Laboratories, Los Angeles, CA), which was closed at one end with epoxy glue (Epoxy; Loctite, Düsseldorf, Germany). The inlet and outlet of the microdialysis probe were composed of two sections of fused silica tubing (length: 15 cm; ID: 40 m; OD: 103 m; Polymicro Technologies, Phoenix, AZ), placed inside the membrane. Two insulated wires (Nichrome/Formvar wire, A-M Systems, Carlsborg, WA; bare diameter: 0.0020 in.; coated diameter: 0.0026 in.) were also inserted into the membrane. The wires were inserted into the membrane alongside the inlet-and outlet tubes and positioned so that the wire tips were separated by 2.5 mm. The impedance of individual wires, measured at 1,000 Hz, was about 250 k⍀, and the entire bipolar system had an impedance of about 500 k⍀. Measured at 30 Hz, the impedance was about 750 k⍀ for single wires and about 1.5 M⍀ for the bipolar electrode system.
The probe assembly was placed into a polyimide sleeve (OD: 0.25 mm; length: 12.5 cm; MicroLumen, Tampa, FL). The recording wires were then connected via an impedance adaptor (Model HZP High Impedance Probe, Grass, West Warwick, RI) to an amplifier (Model 8 -16 Amplifier; Grass) for bipolar (differential) amplification and filtering (0.1-75 Hz). In all cases, the more proximal wire was connected to the positive (noninverting) pole of the amplifier. We recently published a detailed description of the assembly and characteristics of this system (Darbin et al. 2006) .
Microdialysis/LFP recording experiments
For each recording session, the animal was seated in a primate chair, with its head fixed in position. In preliminary sessions, we delineated the borders of the striatum by electrophysiologic mapping with conventional tungsten microelectrodes (impedance: 0.7-1 M⍀, measured at 1,000 Hz; FHC, Bowdoinham, ME) and standard electrophysiologic single-unit recording methods (see also Soares et al. 2004) . For each of the microdialysis/LFP recording experiments, we targeted the posterior portion of the putamen between A10 mm and A14 mm, based on the previously generated electrophysiological maps. Each experiment was performed in a previously unused location in the striatum. Prior to the microdialysis experiment, the microdialysis/LFP recording system was perfused overnight with distilled water at a rate of 0.5 l/min delivered by gastight 1-ml syringes (CMA, Solna, Sweden), operated by a microinfusion pump (CMA/ 120; CMA). Thirty minutes before insertion into the brain, the system was perfused with artificial cerebrospinal fluid (aCSF; composition in mM: 147.0 Na ϩ , 4.0 K ϩ , 1.0 Mg 2ϩ , 1.2 Ca 2ϩ , and 153.2 Cl Ϫ ; CMA), at a rate of 1 l/min. Transitions between perfusion solutions were accomplished using a liquid switch (CMA/110; CMA). The probe was mounted to a microdrive (MO-95B, Narishige, Tokyo, Japan) and slowly lowered through a guide tube (modified CMA/11 guide system; CMA) through the dura, into the brain. After a 60-min equilibration period, we started the LFP recordings. For this, the recording wires within the microdialysis system were connected via an impedance adaptor to an amplifier for amplification and filtering (see earlier text). The same amplifier and filter conditions were also used for the bipolar EEG recordings that were made simultaneously with the LFP recordings, using the implanted epidural EEG electrodes. The amplified LFP and EEG signals were digitized (sampling rate: 500 Hz/channel) and stored to computer disk via a data acquisition system (Power 1401 with Spike2 interface; CED, Cambridge, UK) for later off-line analysis. Throughout the experiments, the behavior of the animal was carefully observed and videotaped. Together with EEG monitoring, the behavioral observations demonstrated that the animals were fully awake during the experiments.
Preparation of drug solutions and protocol of administration
All agents used in this study were freshly dissolved in aCSF. In the first set of microdialysis/LFP recording experiments, we examined the effects of local intrastriatal application of the GABA A -receptor antagonist gabazine [2-(3-carboxypropyl)-3-amino-6-methoxyphenylpyridazinium bromide (SR95531), Tocris Bioscience, Ellisville, MO; 0.1-500 M] or of the GABA B -receptor antagonist CGP55845 [(2S)-3-[[(1S)-1-(3,4-dichlorophenyl) ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid; Tocris Bioscience; 100 M]. These drugs were administered for 20 min, starting 40 min after the beginning of the recording session. In other experiments, gabazine was applied together with the GABA A -receptor agonist, muscimol (Sigma, St. Louis, MO; 100 M), or with a combination of the ionotropic glutamate receptor blockers, MK-801 [(ϩ)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate] and CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) (100 M each, blocking N-methyl-D-aspartate and ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors, respectively; Tocris Bioscience). Perfusion with these drugs began 20 min before, and continued throughout, the administration of gabazine (10 M). The volume of tissue that is affected by the drugs was not directly investigated in this study. A previous study of this topic reported that such effects can be noted at distances Յ1 mm away from the microdialysis probe (Westerink and De Vries 2001) . It is difficult to generalize such estimates because they are strongly dependent on the specific pharmacologic properties of the drugs under study, but it is very likely that the direct pharmacologic effects of the drugs used in our study occurred within the striatal tissue surrounding the probes.
Combined recording of single-cell activity, LFP signals, and EEG signals
We found that gabazine infusion resulted in prominent LFP changes (see following text). This prompted us to study the effects of gabazine on the activity of single striatal neurons, to explore how this is related to the LFPs. For these studies, a multielectrode microdrive (NAN Instruments, Nazareth, Israel) was used to introduce both the microdialysis/LFP recording device and a standard tungsten microelectrode (see earlier text) into the striatum. This device provides independent control of the depths of the two probes. The microelectrode and microdialysis/LFP recording device were lowered into the brain through separate guide tubes. The electrodes were introduced 1-3 mm lateral or medial to the microdialysis system. LFP signals were amplified as described earlier. The electrical signals recorded through the microelectrodes were amplified (DAM-80; World Precision Instruments, Sarasota, FL), filtered (400 -10,000 Hz; Krohn-Hite, Brockton, MA), displayed on a digital oscilloscope (DL1540; Yokogawa, Tokyo, Japan), and made audible via an audio amplifier. The amplified signals from the microelectrodes were digitized at 25,000 Hz (Power1401 and Spike2, CED) and stored to computer disk, along with the LFP and EEG signals described earlier. The electrical activity from the microelectrode was sampled before and 20 -60 min after the start of the gabazine (10 M) administration through the microdialysis/LFP recording device, along with LFP and EEG signals. In these experiments, gabazine was applied repeatedly (two to three times per experiment, at 30-min intervals) to maintain the stability of the observed LFP changes.
A frequent bias in in vivo striatal recordings results from the fact that MSNs have very low firing activity, whereas several types of interneurons fire spontaneously. This may lead to a disproportionate representation of interneurons. To minimize this bias, the electrodes were advanced along the electrode path through the striatum in 250-m steps, with pauses at each location for several minutes, even if no neuronal activity was detected initially. This allowed us to detect neurons of low activity, along with neurons with a tonic firing pattern. Before and after gabazine application, we recorded from all of the neurons encountered in the striatum with the recording electrode. This procedure did not completely eliminate recording biases, but it reduced the likelihood that there were substantial differences in the distributions of neuron types sampled before and after gabazine administration.
Analysis
ANALYSIS OF STRIATAL LFPS. Gabazine induced recurring largeamplitude fluctuations in the striatal LFP record. We analyzed the LFP data with custom-designed algorithms in Matlab (The MathWorks, Natick, MA). The stored LFP signals were down-sampled to 241 Hz, digitally filtered between 0.5 and 35 Hz (four-pole Butterworth filter), and then segmented into 10-s "frames." Each frame was screened visually and frames with movement artifacts were rejected. Such artifacts were infrequent, and irregular in shape, and were therefore easily distinguished from the recurring stereotyped LFP events. LFP events were identified on the basis of a threshold criterion. The events were displayed on a computer screen and the beginning and the end of each individual gabazine-induced event was marked by visual inspection. The computer program reported the overall duration of the series of gabazine-induced changes in each experiment, the number of LFP events, and the average duration of the events in consecutive 5-min epochs, starting with the moment of injection of gabazine.
In addition to the individual LFP events, we also observed closely spaced strings of large-amplitude LFP fluctuations that lasted for Ͼ5 s. Facial movements and other behavioral changes were noted during a few of these experiments and confirmed later in the videotaped records.
ANALYSIS OF NEURONAL FIRING RATES AND CORRELATION BETWEEN
SPIKING ACTIVITY AND LFPS. Neuronal spikes were identified in the stored neuronal signal traces by applying a waveform-matching spikesorting algorithm with subsequent principal component analysis (Spike2). The timing of spike occurrences was imported into Matlab and expressed in terms of interspike intervals (ISIs). The relationship between LFPs and changes in the neuronal spiking rates of simultaneously recorded neurons was explored with cross-correlation analyses of the LFP data and the ISI series, convolved with a Gaussian kernel (sigma ϭ 50 ms). The 1st and 99th percentiles of data from cross-correlograms obtained from 100 shuffled representations of the ISI data streams were used as the limits of the confidence interval. Although it would have been highly interesting to examine separate groups of neurons in the striatum, we did not attempt to separate the recorded neurons into MSNs or interneurons because it is not clear whether the criteria that can be used for the classification of striatal neurons in the normal state (such as the firing frequency, the duration of the action potential, or the degree of regularity of firing) still apply after blockade of GABA A receptors. Instead, the analysis of the effects of gabazine on striatal neuronal activity is based on analyses of the activities of the entire population of cells recorded before and after drug administration.
EEG ANALYSIS AND CORRELATIONS TO STRIATAL LFPS. Prior to further processing, EEG records were screened by visual examination of 10-s frames (see earlier text) and frames with artifacts were rejected; thus Ͻ1% of the total length of the record was rejected. The remaining sections of EEG were analyzed to determine whether the LFP events in the striatum were associated with EEG changes.
We first calculated the cross-correlation between the EEG signals and the striatal LFP signals to determine the temporal progression of the LFP-EEG interactions. For this, the absolute values of crosscorrelograms (calculated with a lag of Ϯ1,000 ms), based on successive 10-s segments of data, were integrated and averaged over 5-min periods. The data describing the correlations during and after drug administration were expressed as a percentage of the basal values observed before drug administration.
To analyze the direct relationship between the LFP events and events seen in the cortical EEG, we also calculated averages of 2-s EEG segments, centered on individual LFP events. For the display in Fig. 10 , these segments were averaged over consecutive 20-min periods to characterize the time course of the effect of gabazine administration.
STATISTICS. Throughout this study, we used nonparametric methods for statistical testing. The data were expressed as medians with 25th-75th percentiles. Kruskal-Wallis and Mann-Whitney tests were used for between-group comparisons. Correlation coefficients were calculated using the Spearman correlation test (Siegel 1989) . A P value of Ͻ0.05 was considered to be evidence of a significant difference.
R E S U L T S
Gabazine induces LFP changes
The microdialysis-LFP recording device allowed us to administer drugs by reverse microdialysis and to record simultaneous local field potentials at the same location. Local administration of gabazine at concentrations of 10 M (n ϭ 8 experiments; Figs. 1, 2, and 4) and 500 M (n ϭ 6; Figs. 2, 3, and 4) with this device induced large repetitive LFP events in the striatum. These events occurred as discrete entities that were of much higher amplitude than that of the background activity. No such events were found at low gabazine concentrations (0.1 M; n ϭ 6), in control recordings in which aCSF was infused (n ϭ 6), or following the administration of the GABA B -receptor antagonist CGP55845 (100 M; n ϭ 4; Fig.  6 ). Note that the occasional spikelike fluctuations in the LFP signal, prior to drug infusion (e.g., see Fig. 1, arrow) , are movement artifacts. Such artifacts were easily distinguished from the LFP events and artifact-containing segments were excluded from the quantitative analyses.
Characteristics of gabazine-induced changes in LFP recordings
The gabazine concentration influenced the shape, duration, amplitude, and frequency (Kruskal-Wallis test, 2 ϭ 21.57, df ϭ 3, P Ͻ 0.001; Fig. 5 ) of the LFP events. As shown in Figs. 2 and 5, gabazine at 10 M induced events with a median duration of 0.47 s (range 0.33-0.64 s), whereas gabazine at 500 M induced longer events (median event duration of 0.74 s, range 0.66 -0.83 s) that were more complex and superimposed on recurrent shifts in baseline potential. The increase in event duration as drug concentration increased was statistically significant (Mann-Whitney U test: U 10M ϭ 26,017, U 500M ϭ 33,667, z ϭ Ϫ10.39, P Ͻ 0.001; Fig. 5C ). In most of the experiments with gabazine 500 M (five of six experiments, 83%), we also observed the intermittent occurrence of episodes of more sustained activity, starting immediately after a largeamplitude LFP fluctuation and continuing for several seconds (median, 24 s; range 15-57 s; Fig. 3) .
In any given experiment, the durations and shapes of individual LFP events changed over time and these changes were also dependent on the concentration of gabazine. As shown in Fig. 5C , with gabazine at 10 M, the durations increased over the first 30 min to reach a maximum of 700 ms (Spearman correlation, r ϭ 0.624, P Ͻ 0.001), followed by gradual shortening over the next 110 min of recording (Spearman correlation, r ϭ Ϫ0.638, P Ͻ 0.001). With 500 M gabazine, the duration increased faster and reached a plateau value of 700 -800 ms that was maintained for the rest of the recording session (Spearman correlation, time 5-140 min, P Ͼ 0.1). The concentration of gabazine was also related to the size of the induced LFP events in individual experiments. Using cumulative dosing of gabazine, we showed that the amplitude of the LFP events increased as gabazine concentrations in the infusate increased (n ϭ 3, Fig. 4) .
Increasing the drug concentration also increased the total number of events per experimental session (Kruskal-Wallis test:
2 ϭ 21.57, df ϭ 3, P Ͻ 0.001; Fig. 5A ) and their frequency at any given point in the recording period (MannWhitney U test: U 10M ϭ 27,545, U 500M ϭ 38,884, z ϭ Ϫ13.66, P Ͻ 0.001; Fig. 5B ). The analysis in Fig. 5 shows that the number of events seen during the recording period after gabazine 500 M (Fig. 5A, median 2,356 ; range 2,263-3,300 events) was more than twice that seen with 10 M (median 1,060, range 762-1,443 events; Mann-Whitney U test: U 10M ϭ 37, U 500M ϭ 54, z ϭ 2.781, P Ͻ 0.005). At 10 M, gabazine-induced events reached their peak frequency (about 60 events/5 min) 10 min after the beginning of the drug administration, followed by a gradual decline over the next 105 min (Spearman correlation r ϭ Ϫ0.614, P Ͻ 0.001; Fig. 5B ). In contrast, with gabazine at 500 M, the frequency of these events continued to increase (to an average of 110 events/5 min) through the first hour after the start of the drug infusion (Spearman correlation, r ϭ Ϫ0.587, P Ͻ 0.002) and did not significantly decline over the remainder of the recording session (Spearman correlation, P Ͼ 0.1; Fig. 5B ).
Effects of coadministration of gabazine with other drugs
As shown in Fig. 6 , coadministration of gabazine (10 M) with the GABA A -receptor agonist muscimol (100 M, n ϭ 6) or with a combination of ionotropic glutamate receptor antagonists (MK-801 and CNQX, each at 100 M, n ϭ 4), given for 40 min, starting 20 min before the gabazine application, completely prevented the gabazine-induced LFP events, but did not affect the amplitude of the background LFP signals. The gabazine-induced effects persisted in the presence of the GABA B -receptor antagonist CGP55845 (100 M).
Gabazine-induced effects on neuronal firing
Using a microdrive capable of independently driving multiple probes, we recorded from cells in the vicinity of the microdialysis/LFP recording device before and after administration of gabazine (10 M). Under control conditions, all of the recorded neurons fired at rates Ͻ1 spike/s (n ϭ 50 cells) and are therefore likely to have been MSNs. After administration of gabazine (n ϭ 26 cells), the average rate increased to 1.9 spikes/s (Mann-Whitney U test: U control ϭ 30, U 10M ϭ 64, z ϭ 5.83; P Ͻ 0.005), with 9 cells firing faster than 3/s, and 3 cells firing at rates Ͼ10 spikes/s. Although the average discharge rate increased after gabazine administration, there was no clear temporal correlation between the LFP events and neuronal firing patterns in 24/26 cells, as is shown in the example recording in Fig. 7 . These cells were recorded during a 90-min period following a single 20-min infusion of gabazine (10 M). In the other two cells, gabazine exposure led to brief episodes of correlation between the LFP signal and neuronal firing (Fig. 8) . Both of these cells fired at high rates (median rates of 28.5 and 40.1 spikes/s, respectively) and were recorded after repeated 20-min applications of gabazine to maintain the same amplitude of the LFPs (two and three times, respectively, over 2 h). Under these conditions, LFP events occurred at a faster rate than in the experiments with only a single 20-min exposure to gabazine (see Fig. 7 for comparison) .
Gabazine-induced changes in the correlation between motor cortex EEG and striatal LFPs
In all experiments, we recorded EEG signals from motor cortex (abbreviated as M1-EEG in Figs. 9 and 10) along with the LFP signals. Visual examination of the EEG after administration of gabazine 500 M (n ϭ 6) in the striatum revealed the appearance of discrete events that were correlated in time with the occurrence of the striatal LFP events (Fig. 9) . Such events were not apparent in the raw traces after the 10 M gabazine (n ϭ 8), but statistical evaluation with cross-correlation methods showed that gabazine administration at both concentrations increased the overall correlation between the EEG and LFP signals. Using integrated absolute cross-correlograms as a measure of correlation, we found that the increase was significant at both 10 and 500 M gabazine (KruskalWallis test, 10 M: 2 ϭ 177, df ϭ 35, P Ͻ 0.001; 500 M: 2 ϭ 93, df ϭ 35, P Ͻ 0.001; Fig. 9B ), and that its magnitude depended on the drug concentration (Mann-Whitney U test: U 10M ϭ 161, U 500M ϭ 280, z ϭ 9.954, P Ͻ 0.005; Fig. 9B ).
We further analyzed the relationship between the LFP events and EEG signals, by averaging segments of EEG occurring around the peaks of the LFP events ( Fig. 10; see METHODS) . This analysis showed that the occurrence of EEG events was temporally linked to the striatal LFP events. As shown in the example in Fig. 10 (top trace) , averaging over 20-min time periods demonstrated EEG changes with both gabazine concentrations. As expected, 500 M gabazine induced stronger cortical involvement than 10 M gabazine (Fig. 10, bottom  trace) . 
Behavioral changes induced by the striatal gabazine infusions
Video images of the animals recorded throughout the gabazine infusions were carefully examined. In most sessions, gabazine administration had no behavioral consequences. However, in two of six sessions in which the highest concentration of gabazine (500 M) was used, we observed facial movements, including eye blinking, chewing, teeth grinding, and excessive salivation. These behaviors started approximately 60 min after beginning the drug infusion and continued for several hours.
D I S C U S S I O N
These data show that intrastriatal administration of the specific GABA A -receptor antagonist gabazine increases the spiking activity of striatal neurons and evokes recurrent largeamplitude LFP fluctuations, parallel to similar changes in motor cortical EEG. Striatal LFP events were not induced by administration of the GABA B -receptor antagonist CGP55845. Pretreatment with the GABA A -receptor agonist muscimol, or with a combination of the ionotropic glutamate receptor antagonists MK-801 and CNQX, prevented the development of the gabazine-induced striatal LFP events. These studies show that baseline GABA A -receptor activation by endogenous GABA under physiologic conditions reduces the activity of striatal neurons and that ambient GABA in the striatum may act to restrain the level of synchrony of activity in the basal gangliathalamocortical circuitry.
Effects of ambient GABA on single-cell activity
Most GABAergic interactions in the striatum involve terminals of intrinsic striatal neurons, including MSNs, which represent the majority of all striatal neurons (see, e.g., Rymar et al. 2004) , and several classes of GABAergic interneurons (Cowan et al. 1990; Kawaguchi 1993; Mallet et al. 2005; Wu and Parent 2000) . Commensurate with the large number of striatal GABAergic synapses, GABA A receptors are ubiquitous in the striatum (Riedel et al. 1998; Waldvogel et al. 2004) , with the majority found at postsynaptic sites (Fujiyama et al. 2000) .
In line with previous in vitro studies in the rat striatum (Kita 1996; Nisenbaum et al. 1992) , we found that intrastriatal administration of a GABA A -receptor antagonist increased the average firing rates of striatal neurons, demonstrating that GABA A receptors tonically inhibit striatal cells in the monkey. Althoughe we are unable to establish unequivocally the identity of the recorded neurons in the in vivo recordings, several points can be raised to address this question. Given the very low firing rates, and the statistical likelihood of encountering MSNs, most of the neurons recorded in the pregabazine phase of the recording sessions can be assumed to be MSNs. It is likely that the majority of neurons in the postgabazine sample of neurons were also MSNs because the median postgabazine firing rate was 1.9 spikes/s, which is below the average spontaneous firing rate of tonically active neurons or fast-spiking cells (see, e.g., Aosaki et al. 1994 Aosaki et al. , 1995 Morris et al. 2004; Raz et al. 1996) . However, cells spiking at higher rates were also found, suggesting that at least some of the postgabazine recordings may have been from tonically active cholinergic cells or other interneurons.
Gabazine is likely to have acted at GABA A receptors on striatal neurons that were at baseline exposed to endogenous GABA. The gabazine effects may have differed between the types of neurons and synaptic sites at which it acted. MSNs receive GABAergic axon collaterals from neighboring MSNs (Kawaguchi 1993; Loopuijt and van der Kooy 1985) , but the low intrinsic activity of MSNs and the fact that the collaterals terminate distally on dendrites of other MSNs suggest that axon collateral interactions between MSNs are relatively weak (Czubayko and Plenz 2002; Jaeger et al. 1994 Jaeger et al. , 1995 Koos et al. 2004; Stern et al. 1998; Taverna et al. 2004; Tecuapetla et al. 2005; Tunstall et al. 2002; Venance et al. 2004) , so that GABA A -receptor blockade at these sites is less likely to have had prominent effects. It is more likely that most GABAergic inhibition of MSNs originates from GABAergic interneurons and that gabazine exerted prominent effects at these sites. The activity of (fast-spiking) interneurons is substantially higher than that of MSNs and they provide synaptic input closer to the soma of MSN cells (Gustafson et al. 2006; Hellgren Kotaleski et al. 2006; Koos et al. 2004; Mallet et al. 2005; . GABAergic input from fast-spiking interneurons to MSNs may be influenced by glutamatergic inputs from cortex and thalamus and may provide feedforward inhibition to MSNs (Mallet et al. 2005; Parthasarathy and Graybiel 1997) .
GABAergic inputs to striatal interneurons also originate from several sources and GABA-receptor blockade at these sites, counteracting an ambient GABAergic tone, may have contributed to the changes in neuronal spiking. Given the preceding considerations, the inputs from GABAergic interneurons are likely to be substantially more important than those from MSNs. Cholinergic interneurons receive GABAergic input predominately from MSN collaterals (Martone et al. 1992) . Interestingly, despite the aforementioned low intrinsic activity along MSN collaterals, the GABAergic tone afforded by these inputs onto cholinergic cells appears to be substantial (Zackheim and Abercrombie 2005) .
The influence of other striatal systems exposed to ambient GABA to the effects seen in our results is more difficult to gauge. It is known that neurons in the external pallidal segment (GPe) send a GABAergic projection to the striatum (Bevan et al. 1998; Kita 2007; Sadek et al. 2007; Sato et al. 2000; Smith and Parent 1986) , but the cellular target of this projection is not clear. Nonneuronal sources of GABA release (Campbell et al. 1993 ) may also contribute to the overall GABA level, and thus to the effects of gabazine on cellular firing.
Effects of ambient GABA on striatal LFP and cortical EEG signals
Local intrastriatal application of gabazine had prominent effects on striatal LFPs. We have previously shown that striatal LFPs recorded under the conditions used in this study are not correlated with cortical EEGs (see also Darbin et al. 2006) . The bipolar montage used in our LFP recordings minimizes the influence of distant electrical activity, which would reach each electrode similarly by volume conduction. Considering the ratio between the amplitude of the gabazine-evoked LFP events and the amplitude of the background activity recorded in the striatum before gabazine exposure, it is likely that the gabazine-related events were the product of synchronous activities generated close to the LFP recording electrode (see also Bedard et al. 2004; Brown and Williams 2005; Goldberg et al. 2004 ). We will consider several possibilities to explain the LFP and EEG findings.
The general lack of correlation between the LFP events and simultaneously recorded single-unit activity suggests that synchronous subthreshold synaptic currents generated in the vicinity of the electrode were a major contributor to the LFP signals (see also discussions in Darbin et al. 2006; Galvan et al. 2002; Kaur et al. 2004; Norena and Eggermont 2002) . GABA A -receptor blockade with gabazine is likely to have interrupted most synaptic interactions among neurons intrinsic to the striatum. Thus it is likely that the postgabazine LFP events were in large part driven by synchronous activities of striatal afferents, resulting in similarly synchronous postsynaptic potentials. This is further supported by the fact that ionotropic glutamate receptor antagonists blocked the emergence of the gabazine-induced LFP events (Bracci et al. 2004; Hu and Wang 1988; Sandstrom and Rebec 2003) , likely acting at synapses of glutamatergic inputs originating from cortex (Kemp and Powell 1970) or thalamus (Smith et al. 2004) .
We also found that blockade of striatal GABA A receptors increased the correlation between the striatal LFP and motor cortical EEG signals. This is most easily explained in terms of the influence of striatal (and thus basal ganglia) output on cortical activity. However, the fact that the correlated EEG/ LFP activities occurred without clear entrainment of striatal output neurons by the LFP events suggests that striatal gabazine administration did not directly produce oscillatory spiking activity in individual striatal output neurons, but that it may have primarily acted to increase striatal output, which then led to the emergence of rhythmic synchronous activity in areas outside of the striatum, for instance, cortex or thalamus. The LFP events would have resulted from synaptic activity at the sites of the returning glutamatergic inputs from cortex or thalamus.
Another possibility to consider is that at least some of the LFP activity was generated by spontaneous burst firing of striatal interneurons. In fact, the two cells that exhibited a firing pattern that was temporarily correlated with the LFP signals showed high firing rates and may have been striatal interneurons. It is known that some striatal interneuron types, specifically cholinergic and fast-spiking interneurons, are capable of generating rhythmic bursts at rates that are comparable to those at which the LFP events occurred in our study (Bennett and Wilson 1999; Bracci et al. 2003; Kawaguchi 1993; Kita 1993; Koos and Tepper 1999, 2002; Pisani et al. 2007; Plenz and Kitai 1998) . Importantly, these interneurons may express synchronized firing patterns (e.g., Bauer et al. 1995; Collins et al. 2001; Courtemanche et al. 2002; Donoghue et al. 1998; Takahashi and Straschill 1981) , which may have played a role in the generation of the LFP events, although this would make the observed EEG changes difficult to explain.
The presence of large LFP events that were not strongly related to neuronal spiking could also be explained by changes in the activity of larger ensembles of striatal cells not detectable in the recording from individual cells, but was sufficient to alter LFP recordings. Such changes in ensemble activity could be transmitted to sites outside of the striatum and could act to entrain thalamic or cortical regions into the oscillatory activity that was generated in the striatum. This possibility could be tested in future experiments through multi-electrode recordings in the striatum and other elements of the basal gangliathalamocortical circuitry.
Effects of GABA A -receptor blockade on behavior
In most of our experiments, gabazine administration in the striatum did not trigger behavioral changes. However, in two experiments in which the highest concentration of gabazine was used, facial twitching and other behavioral effects were seen, suggesting that GABAergic inhibition in the striatum may be one of the mechanisms that normally prevent excessive movements (Crossman et al. 1988; Marsden et al. 1975; Nakamura et al. 1990; Yoshida et al. 1991) . It is possible that reduced inhibition in the striatum may contribute to movement disorders such as some forms of dystonia (Fredow and Loscher 1991; Kreil and Richter 2005; Loscher and Horstermann 1992; Nobrega et al. 1995; Pratt et al. 1995; Richter and Loscher 1993; Yoshida et al. 1991) or myoclonus (Darbin et al. 2000) . GABAergic inhibition in the striatum may also act to inhibit seizure generation (Dematteis et al. 2003) or propagation (e.g., Benedek et al. 2004; Biraben et al. 2004; Bouilleret et al. 2005; Sasaki et al. 2000; Vercueil et al. 1999) . Our experiments show that local blockade of striatal GABA A receptors has substantial effects on the function of the entire basal ganglia-thalamocortical system. Modulation of striatal GABA levels may therefore represent a pharmacological target of interest in the treatment of movement disorders or seizures. 
